RATIONALE: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA) hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction, depressed cardiac performance, and HF after MI. OBJECTIVE: We used a mouse model (RyRS2808A) in which PKA hyperphosphorylation of the RyR2 at Ser-2808 is prevented to determine whether loss of PKA phosphorylation at this site averts post MI cardiac pump dysfunction. METHODS AND RESULTS: MI was induced in wild-type (WT) and S2808A mice. Myocyte and cardiac function were compared in WT and S2808A animals before and after MI. The effects of the PKA activator Isoproterenol (Iso) on L-type Ca(2+) current (I(CaL)), contractions, and [Ca(2+)](I) transients were also measured. Both WT and S2808A mice had depressed pump function after MI, and there were no differences between groups. MI size was also identical in both groups. L type Ca(2+) current, contractions, Ca(2+) transients, and SR Ca(2+) load were also not significantly different in WT versus S2808A myocytes either before or after MI. Iso effects on Ca(2+) current, contraction, Ca(2+) transients, and SR Ca(2+) load were identical in WT and S2808A myocytes before and after MI at both low and high concentrations. CONCLUSIONS: These results strongly support the idea that PKA phosphorylation of RyR-S2808 is irrelevant to the development of cardiac dysfunction after MI, at least in the mice used in this study.
RATIONALE: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA) hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction, depressed cardiac performance, and HF after MI. OBJECTIVE: We used a mouse model (RyRS2808A) in which PKA hyperphosphorylation of the RyR2 at Ser-2808 is prevented to determine whether loss of PKA phosphorylation at this site averts post MI cardiac pump dysfunction. METHODS AND RESULTS: MI was induced in wild-type (WT) and S2808Amice. Myocyte and cardiac function were compared in WT and S2808A animals before and after MI. The effects of the PKA activator Isoproterenol (Iso) on L-type Ca(2+) current (I(CaL)), contractions, and [Ca(2+)](I) transients were also measured. Both WT and S2808Amice had depressed pump function after MI, and there were no differences between groups. MI size was also identical in both groups. L type Ca(2+) current, contractions, Ca(2+) transients, and SRCa(2+) load were also not significantly different in WT versus S2808A myocytes either before or after MI. Iso effects on Ca(2+) current, contraction, Ca(2+) transients, and SRCa(2+) load were identical in WT and S2808A myocytes before and after MI at both low and high concentrations. CONCLUSIONS: These results strongly support the idea that PKA phosphorylation of RyR-S2808 is irrelevant to the development of cardiac dysfunction after MI, at least in the mice used in this study.
Authors: Scott A Henderson; Joshua I Goldhaber; Jessica M So; Tieyan Han; Christi Motter; An Ngo; Chana Chantawansri; Matthew R Ritter; Martin Friedlander; Debora A Nicoll; Joy S Frank; Maria C Jordan; Kenneth P Roos; Robert S Ross; Kenneth D Philipson Journal: Circ Res Date: 2004-08-12 Impact factor: 17.367
Authors: Ming Tao Jiang; Andrew J Lokuta; Emily F Farrell; Matthew R Wolff; Robert A Haworth; Héctor H Valdivia Journal: Circ Res Date: 2002-11-29 Impact factor: 17.367
Authors: Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; John A Vest; Anetta Wronska; Andrew R Marks Journal: Proc Natl Acad Sci U S A Date: 2006-01-06 Impact factor: 11.205
Authors: Scott M MacDonnell; Gerardo García-Rivas; Joseph A Scherman; Hajime Kubo; Xiongwen Chen; Héctor Valdivia; Steven R Houser Journal: Circ Res Date: 2008-04-03 Impact factor: 17.367
Authors: Roland Vetter; Uwe Rehfeld; Christoph Reissfelder; Wolfgang Weiss; Kay-Dietrich Wagner; Joachim Günther; Annette Hammes; Carsten Tschöpe; Wolfgang Dillmann; Martin Paul Journal: FASEB J Date: 2002-08-21 Impact factor: 5.191
Authors: Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang Journal: Circ Res Date: 2014-10-27 Impact factor: 17.367
Authors: Hideshi Okada; N Chin Lai; Yoshitaka Kawaraguchi; Peter Liao; Jeffrey Copps; Yasuo Sugano; Sunaho Okada-Maeda; Indroneal Banerjee; Jan M Schilling; Alexandre R Gingras; Elizabeth K Asfaw; Jorge Suarez; Seok-Min Kang; Guy A Perkins; Carol G Au; Sharon Israeli-Rosenberg; Ana Maria Manso; Zheng Liu; Derek J Milner; Stephen J Kaufman; Hemal H Patel; David M Roth; H Kirk Hammond; Susan S Taylor; Wolfgang H Dillmann; Joshua I Goldhaber; Robert S Ross Journal: J Clin Invest Date: 2013-09-16 Impact factor: 14.808
Authors: Larry A Barr; Catherine A Makarewich; Remus M Berretta; Hui Gao; Constantine D Troupes; Felix Woitek; Fabio Recchia; Hajime Kubo; Thomas Force; Steven R Houser Journal: Clin Transl Sci Date: 2014-06-16 Impact factor: 4.689